Rega marang bathi mangsa ngarep: lexeotx.com (LXEO)
Lexeo Therapeutics (LXEO) specializes in developing innovative genetic drugs and diagnostic systems. This chart of stock quotes confirms the asset's market value, where the P/E ratio stands at 0.00. Complex certification regulations and patent protection for DNA delivery methods limit the entry of new players. A long-term advantage is provided by unique AAV vectors for the therapy of cardiomyopathies and Alzheimer's disease, creating a significant barrier for competitors.
Rincian metrik keuangan lan pasar Lexeo (LXEO)
- kuotasi lan prakiraan analis:
- indikator kapitalisasi bursa perusahaan:
- data ekuitas miturut neraca:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal Lexeo Therapeutics|LXEO - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal Lexeo Therapeutics|LXEO - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku Lexeo Therapeutics Inc.|LXEO - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Lexeo Therapeutics|Likuiditas cepet lexeotx.com
- rincian asil keuangan lan kelipatan valuasi:
LXEO - Bathi sawise pajeg|Proyeksi bathi mangsa ngarep Lexeo Therapeutics|LXEO - Kapitalisasi marang bathi|Prakiraan rega marang bathi Lexeo Therapeutics|LXEO - Pangali PEG|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Lexeo Therapeutics Inc.|LXEO - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|Bathi resik saben saham (EPS TTM) Lexeo Therapeutics|LXEO - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan lexeotx.com|LXEO - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Lexeo Therapeutics
- informasi babagan volume dodolan lan pendapatan:
Analisis kabeh metrik perusahaan:LXEO Lexeo Therapeutics, Inc.
Lexeo Therapeutics (LXEO) is independently developing its gene pipeline without the involvement of external partners. Under these conditions, the business's forward P/E compares current market value with expected net income one year from now. This metric measures the extent to which the asset is overvalued relative to future cash flows. Analyzing the chart's trajectory allows for the distinction between market noise and a real decline in laboratory efficiency. This determines whether the price is a fair reflection of organic growth.
Pesaing langsung
Pangali Forward P/E TEM|QGEN - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Ionis Pharma IONS|Repligen Inc. (RGEN) - Rasio prakiraan rega marang bathi|RNA: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi CRSP (crisprtx.com)|WGS (GeneDx) - Prakiraan rega marang bathi|RARE: Rasio kapitalisasi marang bathi mangsa ngarep|BEAM (Beam Therapeutics Corp) - Pangali Forward P/E|SRPT: Pangali mangsa ngarep rega marang bathi|Pangali Forward P/E TWST|TXG - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Intellia Therapeutics, Inc. NTLA|Pangali mangsa ngarep rega marang bathi STOK|BioLife Corp - Pangali Forward P/E|WVE - Pangali Forward P/E|Maze Therapeutics Inc (MAZE) - Rega marang bathi mangsa ngarep|Rasio rega marang bathi sing dikarepake SION (sionnatx.com)|PRME (Prime Medicine) - Pangali Forward P/E|Rasio prakiraan rega marang bathi Taysha Gene Therapies Inc TSHA|Prakiraan rega marang bathi QURE (uniQure Corp)|Pangali Forward P/E MeiraGTx Corp (MGTX)|REGENXBIO Inc. - Prakiraan rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep SLDB (solidbio.com)|Ocugen - Pangali Forward P/E|Kapitalisasi marang proyeksi bathi Pacific Biosciences of California, Inc. PACB|BNTC: Pangali Forward P/E|Prakiraan rega marang bathi Design Corp|Rega marang bathi mangsa ngarep Rocket Pharmaceuticals|4dmoleculartherapeutics.com (FDMT) - Kapitalisasi marang proyeksi bathi|Rega marang bathi mangsa ngarep Korro Bio, Inc. (KRRO)|Rega marang bathi mangsa ngarep EDIT (Editas Medicine Inc)|Silence Therapeutics Inc. - Prakiraan rega marang bathi|PRQR: Rasio rega marang bathi mangsa ngarep|Codexis Bio - Pangali Forward P/E|Rasio prakiraan rega marang bathi sangamo.com|nautilus.bio (NAUT) - Rega marang bathi mangsa ngarep|Rasio prakiraan rega marang bathi Metagenomi Inc. (MGX)|DTIL (Precision BioSciences, Inc.) - Pangali Forward P/E|Rasio rega marang bathi mangsa ngarep GBIO (Generation Bio Corp)|Rega marang bathi mangsa ngarep Boundless Bio, Inc. (BOLD)|exicuretx.com - Rasio rega marang bathi mangsa ngarep|Pangali Forward P/E IMNN (Imunon)|Pangali Forward P/E Phio Pharmaceuticals Corp PHIO|MBIO - Rega marang bathi mangsa ngarep|RNAZ: Rega marang bathi mangsa ngarep|BNGO: Pangali Forward P/E|Rasio prakiraan rega marang bathi adnas.com (APDN)|Prakiraan rega marang bathi BLUE|Rasio rega marang bathi mangsa ngarep IPA (ImmunoPrecise)|Pangali Forward P/E OMGA|OMIC - Rasio prakiraan rega marang bathi|Rega marang bathi mangsa ngarep Regulus Therapeutics RGLS|syros.com (SYRS) - Rasio prakiraan rega marang bathi|TBIO: Prakiraan rega marang bathi|Pangali mangsa ngarep rega marang bathi TCON (TRACON Pharmaceuticals Inc.)|UBX (Unity Bio) - Prakiraan rega marang bathi
